NASDAQ:FENC - Fennec Pharmaceuticals Stock Price, Forecast & News

Fennec Pharmaceuticals trades on the NASDAQ under the ticker symbol "FENC."

Fennec Pharmaceuticals Inc (NASDAQ:FENC) announced its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.09) EPS for the quarter, beating analysts' consensus estimates of ($0.20) by $0.11. View Fennec Pharmaceuticals' Earnings History.

Fennec Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Fennec Pharmaceuticals.

2 analysts have issued 1-year price targets for Fennec Pharmaceuticals' stock. Their forecasts range from $16.00 to $17.00. On average, they anticipate Fennec Pharmaceuticals' stock price to reach $16.50 in the next twelve months. This suggests a possible upside of 165.7% from the stock's current price. View Analyst Price Targets for Fennec Pharmaceuticals.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fennec Pharmaceuticals in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fennec Pharmaceuticals.

News coverage about FENC stock has been trending very positive recently, InfoTrie reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Fennec Pharmaceuticals earned a news sentiment score of 3.7 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Fennec Pharmaceuticals.

Fennec Pharmaceuticals saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 469,400 shares, an increase of 10.4% from the December 15th total of 425,000 shares. Based on an average daily volume of 29,300 shares, the short-interest ratio is currently 16.0 days. Approximately 2.9% of the company's stock are short sold. View Fennec Pharmaceuticals' Current Options Chain.

Some companies that are related to Fennec Pharmaceuticals include Translate Bio (TBIO), Adaptimmune Therapeutics (ADAP), Aptose Biosciences (APTO), BioCryst Pharmaceuticals (BCRX), Gritstone Oncology (GRTS), Cabaletta Bio (CABA), PDL BioPharma (PDLI), Harpoon Therapeutics (HARP), Eiger Biopharmaceuticals (EIGR), Tcr2 Therapeutics (TCRR), Cellular Biomedicine Group (CBMG), Scholar Rock (SRRK), Compugen (CGEN), CASI Pharmaceuticals (CASI) and Sutro Biopharma (STRO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Fennec Pharmaceuticals investors own include Iovance Biotherapeutics (IOVA), Amarin (AMRN), Fate Therapeutics (FATE), Karyopharm Therapeutics (KPTI), Allena Pharmaceuticals (ALNA), Coherus Biosciences (CHRS), Denali Therapeutics (DNLI), Pieris Pharmaceuticals (PIRS), Aptose Biosciences (APTO) and Cidara Therapeutics (CDTX).

Fennec Pharmaceuticals' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Wedbush Securities Inc. (0.12%). View Institutional Ownership Trends for Fennec Pharmaceuticals.

FENC stock was purchased by a variety of institutional investors in the last quarter, including Wedbush Securities Inc.. View Insider Buying and Selling for Fennec Pharmaceuticals.

Shares of FENC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of FENC stock can currently be purchased for approximately $6.21.

Fennec Pharmaceuticals has a market capitalization of $123.58 million. The company earns $-9,890,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. View Additional Information About Fennec Pharmaceuticals.

The official website for Fennec Pharmaceuticals is http://www.fennecpharma.com/.

Fennec Pharmaceuticals' mailing address is PO BOX 13628 68 TW ALEXANDER DRIVE, DURHAM NC, 27709. The company can be reached via phone at 919-636-4530.